Basal serum levels and reactivity of nerve growth factor and brain-derived neurotrophic factor to standardized acute exercise in multiple sclerosis and controls.

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMID 12742659)

Published in J Neuroimmunol on May 01, 2003

Authors

Stefan M Gold1, Karl-Heinz Schulz, Sten Hartmann, Mila Mladek, Undine E Lang, Rainer Hellweg, Rüdiger Reer, Klaus-Michael Braumann, Christoph Heesen

Author Affiliations

1: Department of Neurology, University Hospital Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. gold@uke.uni-hamburg.de

Articles citing this

Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. J Neurosci (2010) 1.90

Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging. Mayo Clin Proc (2011) 1.79

Bridging animal and human models of exercise-induced brain plasticity. Trends Cogn Sci (2013) 1.79

The influences of environmental enrichment, cognitive enhancement, and physical exercise on brain development: can we alter the developmental trajectory of ADHD? Neurosci Biobehav Rev (2010) 1.20

Aerobic fitness is associated with gray matter volume and white matter integrity in multiple sclerosis. Brain Res (2009) 1.18

Exercise and disease progression in multiple sclerosis: can exercise slow down the progression of multiple sclerosis? Ther Adv Neurol Disord (2012) 1.12

Effects of aerobic exercise on cognitive performance and individual psychopathology in depressive and schizophrenia patients. Eur Arch Psychiatry Clin Neurosci (2014) 1.10

A randomised, controlled study on the effects of a short-term endurance training programme in patients with major depression. Br J Sports Med (2006) 1.08

Strength training does not influence serum brain-derived neurotrophic factor. Eur J Appl Physiol (2010) 0.97

Exploring exercise as an avenue for the treatment of anxiety disorders. Expert Rev Neurother (2012) 0.94

Physical Activity Effects on Depressive Symptoms in Black Adults. J Health Dispar Res Pract (2010) 0.94

Exercise, nutrition and the brain. Sports Med (2014) 0.92

Emerging support for a role of exercise in attention-deficit/hyperactivity disorder intervention planning. Curr Psychiatry Rep (2012) 0.92

Development of a method that eliminates false-positive results due to nerve growth factor interference in the assessment of fulranumab immunogenicity. AAPS J (2014) 0.91

The influence of a mild thermal challenge and severe hypoxia on exercise performance and serum BDNF. Eur J Appl Physiol (2015) 0.91

Association among basal serum BDNF, cardiorespiratory fitness and cardiovascular disease risk factors in untrained healthy Korean men. Eur J Appl Physiol (2010) 0.90

Physical activity and cognitive trajectories in cognitively normal adults: the adult children study. Alzheimer Dis Assoc Disord (2014) 0.89

Exercise in multiple sclerosis -- an integral component of disease management. EPMA J (2011) 0.87

Different circulating brain-derived neurotrophic factor responses to acute exercise between physically active and sedentary subjects. J Sports Sci Med (2012) 0.87

Aerobic exercise modulates intracortical inhibition and facilitation in a nonexercised upper limb muscle. BMC Sports Sci Med Rehabil (2014) 0.86

The recent understanding of the neurotrophin's role in skeletal muscle adaptation. J Biomed Biotechnol (2011) 0.86

The effect of exercise training modality on serum brain derived neurotrophic factor levels in individuals with type 2 diabetes. PLoS One (2012) 0.85

The effects of aerobic exercise intensity and duration on levels of brain-derived neurotrophic factor in healthy men. J Sports Sci Med (2013) 0.84

Cognitive and physiological effects of an acute physical activity intervention in elementary school children. Front Psychol (2014) 0.84

Physical exercise during encoding improves vocabulary learning in young female adults: a neuroendocrinological study. PLoS One (2013) 0.83

Innovative Research Design Exploring the Effects of Physical Activity and Genetics on Cognitive Performance in Community-Based Older Adults. J Aging Phys Act (2015) 0.83

The Effect of an Acute Bout of Moderate-Intensity Aerobic Exercise on Motor Learning of a Continuous Tracking Task. PLoS One (2016) 0.82

Exercise does not protect against MPTP-induced neurotoxicity in BDNF haploinsufficient mice. PLoS One (2012) 0.82

Acute strength exercise and the involvement of small or large muscle mass on plasma brain-derived neurotrophic factor levels. Clinics (Sao Paulo) (2010) 0.81

Neuromuscular electrical stimulation and dietary interventions to reduce oxidative stress in a secondary progressive multiple sclerosis patient leads to marked gains in function: a case report. Cases J (2009) 0.80

Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory. Cogn Affect Behav Neurosci (2015) 0.80

The Effects of Acute Physical Exercise on Memory, Peripheral BDNF, and Cortisol in Young Adults. Neural Plast (2016) 0.79

Endurance Exercise as an "Endogenous" Neuro-enhancement Strategy to Facilitate Motor Learning. Front Hum Neurosci (2015) 0.79

Aerobic physical exercise improved the cognitive function of elderly males but did not modify their blood homocysteine levels. Dement Geriatr Cogn Dis Extra (2015) 0.78

Changes in serum BDNF levels associated with moderate-intensity exercise in healthy young Japanese men. Springerplus (2013) 0.78

Attitude towards physical activity in patients with multiple sclerosis: a cohort study. Neurol Sci (2015) 0.77

Treadmill walking during vocabulary encoding improves verbal long-term memory. Behav Brain Funct (2014) 0.77

Increased serum brain-derived neurotrophic factor protein upon hypoxia in healthy young men. J Neural Transm (Vienna) (2009) 0.77

Change in neuroplasticity-related proteins in response to acute activity-based therapy in persons with spinal cord injury. Top Spinal Cord Inj Rehabil (2014) 0.76

Endurance training in MS: short-term immune responses and their relation to cardiorespiratory fitness, health-related quality of life, and fatigue. J Neurol (2013) 0.76

Brain-derived neurotrophic factor concentrations in tetraplegic athletes. Spinal Cord (2015) 0.75

Does Endurance Training Compensate for Neurotrophin Deficiency Following Diabetic Neuropathy? Iran Red Crescent Med J (2016) 0.75

Serum NPY and BNDF response to a behavioral stressor in alcohol-dependent and healthy control participants. Psychopharmacology (Berl) (2011) 0.75

Potential antimalarial activity of Methyl Jasmonate and its effect on lipid profiles in Plasmodium Berghei infected mice. Afr Health Sci (2015) 0.75

Sex-dependent and independent effects of long-term voluntary wheel running on Bdnf mRNA and protein expression. Physiol Behav (2016) 0.75

Computerized cognitive training and brain derived neurotrophic factor during bed rest: mechanisms to protect individual during acute stress. Aging (Albany NY) (2017) 0.75

Effects of treadmill exercise training on cerebellar estrogen and estrogen receptors, serum estrogen, and motor coordination performance of ovariectomized rats. Iran J Basic Med Sci (2015) 0.75

Articles by these authors

Activating mutation of the renal epithelial chloride channel ClC-Kb predisposing to hypertension. Hypertension (2004) 2.32

Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients. Eur Arch Psychiatry Clin Neurosci (2014) 2.18

Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J Neurosci (2005) 2.15

Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) (2005) 1.77

[Criteria for evidence-based patient information]. Z Arztl Fortbild Qualitatssich (2005) 1.64

The attenuated psychosis syndrome in DSM-5. Schizophr Res (2013) 1.61

Animal-assisted therapy and agitation and depression in nursing home residents with dementia: a matched case-control trial. Am J Geriatr Psychiatry (2013) 1.60

Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis. Sci Transl Med (2013) 1.54

Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression. J Neurol Neurosurg Psychiatry (2011) 1.53

BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology (2004) 1.44

Association of BDNF serum concentrations with central serotonergic activity: evidence from auditory signal processing. Neuropsychopharmacology (2005) 1.44

Participation preferences of patients with acute and chronic conditions. Health Expect (2007) 1.40

Serum neurotrophins--a study on the time course and influencing factors in a large old age sample. Neurobiol Aging (2006) 1.38

Voluntary exercise induces anxiety-like behavior in adult C57BL/6J mice correlating with hippocampal neurogenesis. Hippocampus (2010) 1.37

Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs. Nat Med (2013) 1.36

A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis. Ann Neurol (2012) 1.34

Significance of SGK1 in the regulation of neuronal function. J Physiol (2010) 1.32

Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and coordinative function in multiple sclerosis. J Neurol Sci (2004) 1.28

Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures. Mult Scler (2003) 1.19

Biochemical and genetic studies of UBR3, a ubiquitin ligase with a function in olfactory and other sensory systems. J Biol Chem (2007) 1.16

Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity. Biol Psychiatry (2007) 1.14

Deletion of running-induced hippocampal neurogenesis by irradiation prevents development of an anxious phenotype in mice. PLoS One (2010) 1.14

Evolution of donor morbidity in living related liver transplantation: a single-center analysis of 165 cases. Ann Surg (2004) 1.12

Abnormal hippocampal neurochemistry in smokers: evidence from proton magnetic resonance spectroscopy at 3 T. J Clin Psychopharmacol (2007) 1.11

Patients' and observers' perceptions of involvement differ. Validation study on inter-relating measures for shared decision making. PLoS One (2011) 1.11

Evidence-based patient information about treatment of multiple sclerosis--a phase one study on comprehension and emotional responses. Patient Educ Couns (2005) 1.10

Folate deficiency induces neurodegeneration and brain dysfunction in mice lacking uracil DNA glycosylase. J Neurosci (2008) 1.10

Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking. Psychopharmacology (Berl) (2006) 1.09

Transplantation for alcoholic liver disease. J Hepatol (2002) 1.09

Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. Brain Res Mol Brain Res (2004) 1.08

Evidence for impaired cortical inhibition in patients with unipolar major depression. Biol Psychiatry (2005) 1.08

The role of stress-response systems for the pathogenesis and progression of MS. Trends Immunol (2005) 1.05

Cognitive abilities in children after liver transplantation. Transplantation (2005) 1.01

Nature vs. nurture: can enrichment rescue the behavioural phenotype of BDNF heterozygous mice? Behav Brain Res (2008) 1.01

Modafinil effects in multiple sclerosis patients with fatigue. J Neurol (2009) 1.01

Acute exercise ameliorates reduced brain-derived neurotrophic factor in patients with panic disorder. Psychoneuroendocrinology (2009) 1.00

Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain. Brain (2006) 0.99

Impact of actin filament stabilization on adult hippocampal and olfactory bulb neurogenesis. J Neurosci (2010) 0.99

Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse. Neurosci Lett (2004) 0.99

MAPPIN'SDM--the multifocal approach to sharing in shared decision making. PLoS One (2012) 0.97

Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice. J Neurosci (2004) 0.97

Attention and executive functioning deficits in liver-transplanted children. Transplantation (2010) 0.94

Effects of a physical exercise rehabilitation group program on anxiety, depression, body image, and health-related quality of life among breast cancer patients. Onkologie (2011) 0.94

Information provision for people with multiple sclerosis. Cochrane Database Syst Rev (2014) 0.93

A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels. Psychopharmacology (Berl) (2008) 0.92

Effects of cannabis on impulsivity: a systematic review of neuroimaging findings. Curr Pharm Des (2014) 0.92

Decision-making in multiple sclerosis consultations in Italy: third observer and patient assessments. PLoS One (2013) 0.92

Depressive syndromes in neurological disorders. Eur Arch Psychiatry Clin Neurosci (2013) 0.91

Regulation of GluR1 abundance in murine hippocampal neurones by serum- and glucocorticoid-inducible kinase 3. J Physiol (2005) 0.90

Exofocal dopaminergic degeneration as antidepressant target in mouse model of poststroke depression. Biol Psychiatry (2012) 0.90

Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry (2013) 0.90

Brain-derived neurotrophic factor serum concentrations in depressive patients during vagus nerve stimulation and repetitive transcranial magnetic stimulation. Psychopharmacology (Berl) (2006) 0.89

Hyperactivity and enhanced curiosity of mice expressing PKB/SGK-resistant glycogen synthase kinase-3 (GSK-3). Cell Physiol Biochem (2010) 0.89

Implementation of a patient education program on multiple sclerosis relapse management. Patient Educ Couns (2011) 0.89

Responsiveness of patient-based and external rating scales in multiple sclerosis: head-to-head comparison in three clinical settings. J Neurol Sci (2009) 0.89

Chronic cannabis abuse raises nerve growth factor serum concentrations in drug-naive schizophrenic patients. J Psychopharmacol (2003) 0.88

Met carriers of BDNF Val66Met genotype show increased N-acetylaspartate concentration in the anterior cingulate cortex. Neuroimage (2009) 0.88

Differential cognitive effects of cycling versus stretching/coordination training in middle-aged adults. Health Psychol (2011) 0.88

Neurotrophins: from pathophysiology to treatment in Alzheimer's disease. Curr Alzheimer Res (2008) 0.88

Altered cytokine responses to cognitive stress in multiple sclerosis patients with fatigue. Mult Scler (2005) 0.88

Pineal calcification in Alzheimer's disease: an in vivo study using computed tomography. Neurobiol Aging (2006) 0.88

Melatonin treatment of day-night rhythm disturbances and sundowning in Alzheimer disease: an open-label pilot study using actigraphy. J Clin Psychopharmacol (2004) 0.87

Impaired social cognition in multiple sclerosis. J Neurol Neurosurg Psychiatry (2013) 0.87

Effects of right unilateral electroconvulsive therapy on motor cortical excitability in depressive patients. J Psychiatr Res (2005) 0.86

Supportive care needs in patients with cardiovascular disorders. Patient Educ Couns (2013) 0.86

Effects of mitoxantrone on multiple sclerosis patients' lymphocyte subpopulations and production of immunoglobulin, TNF-alpha and IL-10. Eur Neurol (2003) 0.86

Stress-resistant mice overexpressing glucocorticoid receptors display enhanced BDNF in the amygdala and hippocampus with unchanged NGF and serotonergic function. Psychoneuroendocrinology (2006) 0.86

Endocrine and cytokine responses to acute psychological stress in multiple sclerosis. Brain Behav Immun (2002) 0.86

Physical exercise in multiple sclerosis: supportive care or a putative disease-modifying treatment. Expert Rev Neurother (2006) 0.86

Area-specific effects of brain-derived neurotrophic factor (BDNF) genetic ablation on various neuronal subtypes of the mouse brain. Brain Res Dev Brain Res (2005) 0.85

Nerve growth factor serum concentrations in healthy human volunteers: physiological variance and stability. Neurosci Lett (2003) 0.85

Stressful childhood experiences and health outcomes in sexual minority populations: a systematic review. Soc Psychiatry Psychiatr Epidemiol (2014) 0.85

Endocrine and cytokine responses to standardized physical stress in multiple sclerosis. Brain Behav Immun (2003) 0.85

BDNF Val 66 Met and 5-HTTLPR genotype moderate the impact of early psychosocial adversity on plasma brain-derived neurotrophic factor and depressive symptoms: a prospective study. Eur Neuropsychopharmacol (2012) 0.85

Association of human hippocampal neurochemistry, serotonin transporter genetic variation, and anxiety. Neuroimage (2005) 0.85

Rab7 silencing prevents μ-opioid receptor lysosomal targeting and rescues opioid responsiveness to strengthen diabetic neuropathic pain therapy. Diabetes (2012) 0.84

Nerve growth factor serum concentrations rise after successful cognitive-behavioural therapy of generalized anxiety disorder. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.84

Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker for affective disorders? Int J Neuropsychopharmacol (2009) 0.84

MPTP-induced hippocampal effects on serotonin, dopamine, neurotrophins, adult neurogenesis and depression-like behavior are partially influenced by fluoxetine in adult mice. Brain Res (2012) 0.84

PIP5K2A-dependent regulation of excitatory amino acid transporter EAAT3. Psychopharmacology (Berl) (2009) 0.84

A prospective study on living related kidney donors' quality of life in the first year: choosing appropriate reference data. Clin Transplant (2012) 0.83